Commentary on the use of the reproduction number


Journal

Statistical methods in medical research
ISSN: 1477-0334
Titre abrégé: Stat Methods Med Res
Pays: England
ID NLM: 9212457

Informations de publication

Date de publication:
09 2022
Historique:
pubmed: 28 9 2021
medline: 21 9 2022
entrez: 27 9 2021
Statut: ppublish

Résumé

Since the beginning of the COVID-19 pandemic, the reproduction number [Formula: see text] has become a popular epidemiological metric used to communicate the state of the epidemic. At its most basic, [Formula: see text] is defined as the average number of secondary infections caused by one primary infected individual. [Formula: see text] seems convenient, because the epidemic is expanding if [Formula: see text] and contracting if [Formula: see text]. The magnitude of [Formula: see text] indicates by how much transmission needs to be reduced to control the epidemic. Using [Formula: see text] in a naïve way can cause new problems. The reasons for this are threefold: (1) There is not just one definition of [Formula: see text] but many, and the precise definition of [Formula: see text] affects both its estimated value and how it should be interpreted. (2) Even with a particular clearly defined [Formula: see text], there may be different statistical methods used to estimate its value, and the choice of method will affect the estimate. (3) The availability and type of data used to estimate [Formula: see text] vary, and it is not always clear what data should be included in the estimation. In this review, we discuss when [Formula: see text] is useful, when it may be of use but needs to be interpreted with care, and when it may be an inappropriate indicator of the progress of the epidemic. We also argue that careful definition of [Formula: see text], and the data and methods used to estimate it, can make [Formula: see text] a more useful metric for future management of the epidemic.

Identifiants

pubmed: 34569883
doi: 10.1177/09622802211037079
pmc: PMC9277711
mid: NIHMS1815225
doi:

Types de publication

Journal Article Review Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1675-1685

Subventions

Organisme : Medical Research Council
ID : MC_PC_19012
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/V038613/1
Pays : United Kingdom
Organisme : CIHR
Pays : Canada
Organisme : Medical Research Council
ID : MC_PC_19067/2
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R015600/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_19067
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 202562/Z/16/Z
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : R01 AI116770
Pays : United States

Auteurs

Carolin Vegvari (C)

Medical Research Council Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, 4615Imperial College London, London, UK.

Sam Abbott (S)

Center for the Mathematical Modelling of Infectious Diseases, 4906London School of Hygiene & Tropical Medicine, UK.

Frank Ball (F)

School of Mathematical Sciences, 6123University of Nottingham, UK.

Ellen Brooks-Pollock (E)

Bristol Veterinary School, 1980University of Bristol, UK.
NIHR Health Protection Research Unit in Behavioural Science and Evaluation at the University of Bristol, UK.

Robert Challen (R)

EPSRC Centre for Predictive Modelling in Healthcare, 3286University of Exeter, UK.
Somerset NHS Foundation Trust, UK.

Benjamin S Collyer (BS)

Medical Research Council Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, 4615Imperial College London, London, UK.

Ciara Dangerfield (C)

65899Isaac Newton Institute for Mathematical Sciences, UK.

Julia R Gog (JR)

Department of Applied Mathematics and Theoretical Physics, University of Cambridge, UK.

Katelyn M Gostic (KM)

Department of Ecology and Evolution, 2462University of Chicago, USA.

Jane M Heffernan (JM)

Centre for Disease Modelling, Mathematics & Statistics, 7991York University, Canada.
COVID Modelling Task-Force, The Fields Institute, Canada.

T Déirdre Hollingsworth (TD)

Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, 6396University of Oxford, UK.

Valerie Isham (V)

Department of Statistical Science, 4919University College London, UK.

Eben Kenah (E)

Division of Biostatistics, College of Public Health, 2647The Ohio State University, USA.

Denis Mollison (D)

Department of Actuarial Mathematics and Statistics, Heriot-Watt University, UK.

Jasmina Panovska-Griffiths (J)

The Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, UK.
Wolfson Centre for Mathematical Biology, Mathematical Institute and The Queen's College, University of Oxford, Oxford, UK.

Lorenzo Pellis (L)

Department of Mathematics, 5292The University of Manchester, UK.
The Alan Turing Institute, UK.

Michael G Roberts (MG)

School of Natural and Computational Sciences and New Zealand Institute for Advanced Study, Massey University, New Zealand.

Gianpaolo Scalia Tomba (G)

Department of Mathematics, 9318University of Rome Tor Vergata, Italy.

Robin N Thompson (RN)

Mathematics Institute, 2707University of Warwick, Coventry, UK.
Zeeman Institute for Systems Biology and Infectious Disease Epidemiology Research, 2707University of Warwick, Coventry, UK.

Pieter Trapman (P)

Department of Mathematics, 7675Stockholm University, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH